Emisphere Technologies has appointed Michael V. Novinski to the position of president and chief executive officer effective immediately. Mr. Novinski had previously served as  president of Organon USA Inc., a business unit of Organon BioSciences, for the last four years. During that tenure, Organon USA received FDA approval for a number of ethical pharmaceutical products in the areas of Women’s Healthcare, Fertility, Neuroscience, Anti-thrombotics and Anesthesia. Mr. Novinski replaces L...